vancomycin has been researched along with carbapenems in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.22) | 18.7374 |
1990's | 11 (13.41) | 18.2507 |
2000's | 16 (19.51) | 29.6817 |
2010's | 38 (46.34) | 24.3611 |
2020's | 16 (19.51) | 2.80 |
Authors | Studies |
---|---|
Liu, C | 1 |
Reed, RL | 1 |
Andrews, JM; Ashby, JP; Wise, R | 1 |
Chambers, HF | 1 |
Bohnen, JM; DiPiro, JT; Edmiston, CE | 1 |
Suppola, JP; Vaara, M; Valtonen, VV; Volin, L | 1 |
Domon, H; Fukuoka, T; Hirasawa, A; Ishii, C; Kakuta, M; Ohya, S; Utsui, Y; Yasuda, H | 1 |
Asano, K; Fuse, A; Hashizume, T; Nagano, R; Naito, T; Nakagawa, S; Shibata, K | 1 |
Adachi, Y; Hashizume, T; Hazumi, N; Kato, Y; Nakagawa, S; Nakamura, K | 1 |
Kimpara, I; Kudo, E; Kudo, H; Kudo, Y; Miura, T; Saitoh, Y; Sato, S; Tsujino, M | 2 |
Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P | 1 |
Adachi, Y; Hashizume, T; Imamura, H; Morishima, H; Nagano, R; Shibata, K | 1 |
Tateda, K; Yamaguchi, K | 1 |
Sunagawa, M; Ueda, Y | 1 |
Hachiya, T; Kubo, K; Yanagisawa, H | 1 |
Hirai, Y; Kijima, K; Kurazono, M; Nagura, J; Shitara, E; Sugano, T; Takahata, S; Takayama, Y; Tanaka, Y; Yamada, K; Yonezawa, M | 1 |
Kobayashi, Y | 1 |
Koulenti, D; Rello, J | 1 |
Bauer, F; Benca, J; Beno, P; Huttova, M; Kisac, P; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M | 1 |
Bowker, KE; MacGowan, AP; Noel, AR | 1 |
Jayashree, M; Mathew, JL; Ray, P; Singhi, S | 1 |
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kihara, R; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Tsukamoto, K; Yamamoto, Y; Yanagihara, K | 1 |
Gutiérrez, F; Hernández, I; Masiá, M; Matoses, C; Murcia, A; Navarro, A; Padilla, S; Romero, I; Sánchez, V | 1 |
Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Kurihara, S; Morinaga, Y; Nakamura, S; Ohnishi, Y; Seki, M; Yamada, Y; Yamamoto, Y; Yanagihara, K | 1 |
MacDougall, C; Oinonen, M; Pakyz, AL; Polk, RE | 1 |
Choe, KW; Jang, HC; Jeon, JH; Kim, CJ; Kim, EC; Kim, HB; Kim, KH; Kim, NJ; Kim, SH; Lee, S; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
Watanabe, K | 1 |
Medico, CJ; Walsh, P | 1 |
Bogard, KN; Erwin, MW; Fuller, PD; Olsen, KM; Peterson, NT; Plumb, TJ | 1 |
Alış, EE; Cengiz, M; Ekici, S; Turan, G | 1 |
Gray, JW; Patel, M | 1 |
Avazashvili, N; Chikviladze, D; Gachechiladze, Kh; Metreveli, D; Mikeladze, M; Nozadze, T | 1 |
Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
Dowzicky, MJ; Namdari, H; Tan, TY | 1 |
Chen, CM; Chen, WY; Chen, YH; Chen, YS; Cheng, YJ; Chiang, PC; Chuang, YC; Hsu, GJ; Hsueh, PR; Huang, CH; Jang, TN; Ko, WC; Kung, HC; Lee, CM; Lee, MH; Liao, CH; Lin, HC; Liu, CE; Liu, JW; Liu, YC; Lu, CT; Lu, PL; Pan, SC; Shi, ZY; Sun, W; Tsao, SM; Wang, LS; Yang, JL; Yu, KW | 2 |
Choi, SH; Chung, JW; Kim, MN; Kim, SH; Kim, YS; Lee, SO; Sung, H; Woo, JH | 1 |
Coffin, SE; Feng, R; Haynes, K; Kronman, MP; Zaoutis, TE | 1 |
Ambe, LA; Casella, LG; Doi, Y; Ernst, RK; O'Hara, JA; Pelletier, MR; Shanks, RM; Townsend, BM | 1 |
About, F; Berdougo, B; Brun-Buisson, C; De Pontfarcy, A; Delory, T; Emirian, A; Lesprit, P | 1 |
Chamberlain, D; Hendershot, J; Irvine, M; Massoud, N; Vettese, N; Wimer, S | 1 |
Gardner, J; Toledo-Pereyra, LH; Zaffiri, L | 1 |
McKenna, M | 1 |
Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A | 1 |
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
Dubberke, ER; Olsen, MA; Reske, KA; Yan, Y; Zilberberg, M | 1 |
Barbara, CS; Caresta, E; Ceccarelli, G; D'Abramo, A; d'Ettorre, G; Mascellino, MT; Moretti, C; Oliva, A; Papoff, P; Venditti, M; Visca, P; Vullo, V | 1 |
Alby, K; Han, JH; Mills, JP; Talati, NJ | 1 |
Iwanaga, N; Izumikawa, K; Kajihara, T; Kohno, N; Kohno, S; Miyazaki, T; Nakamura, S; Oshima, K; Takazono, T; Yanagihara, K | 1 |
Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC | 1 |
Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
Aggarwal, D; Bradley, W; Carson, ML; Lloyd, BA; Murray, CK; Shaikh, F; Tribble, DR | 1 |
Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
Hollenberg, SM; Khan, ZA | 1 |
Aplenc, R; Arnold, SD; Elgarten, CW; Fisher, BT; Gerber, JS; Huang, YV; Li, Y; Riches, ML; Saber, W | 1 |
Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
Hagiwara, D; Kamada, M; Kamimura, H; Miyazaki, M; Moriwaki, N; Nakano, T; Sato, K; Shiotsuka, S; Takata, T; Togawa, A; Toh, H; Tokushige, C | 1 |
Al Zaibag, M; Aljohany, SM; Alothman, AF; Arabi, YM; Baharoon, S; Balkhy, HH; El-Metwally, A; El-Saed, A | 1 |
Ahmed, I; Rabbi, MB; Sultana, S | 1 |
De Angelis, M; Garzoli, S; Marzuillo, C; Mastroianni, CM; Oliva, A; Ragno, R; Vullo, V | 1 |
Hagiya, H; Hamaguchi, S; Kokado, R; Morii, D; Okuno, H; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H | 1 |
Al Saif, S; Aljohany, SM; Alshaalan, M; AlShehri, A; Balkhy, HH; El-Metwally, A; El-Saed, A; Hijazi, O | 1 |
Brüggemann, RJ; de Wildt, SN; Dia, N; Hartman, SJF; Orriëns, L; Schreuder, MF | 1 |
Margolis, E; Wolf, J | 1 |
Akinci, E; Baran, I; Bodur, H; Mumcuoglu, I; Sertcelik, A | 1 |
Butler, AM; Ford, CD; Forsyth, S; Healy, R; Hoda, D; Jones, PB; Lopansri, BK; Majers, J; Snow, G; Webb, BJ | 1 |
Al Nasser, W; Alghoribi, M; Aljohany, SM; Almohrij, SA; Almunif, S; Alothman, A; Alqahtani, S; Alsaedi, A; Alshamrani, MM; Arabi, Y; Balkhy, HH; Bonnie, HB; El Gammal, A; El-Saed, A | 1 |
Appel, TM; Correa, A; De La Cadena, E; Mojica, MF; Pallares, CJ; Villegas, MV | 1 |
Bruns, AHW; de Groot, MCH; Niessen, FA; Raijmakers, RAP; van der Bruggen, T; van Mourik, MSM | 1 |
Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR | 1 |
Neville, LF; Rendell, JT; Shalit, I; Warn, PA | 1 |
Hrynchuk, OB; Ishchak, OM; Kolesnik, AV; Rud, VO; Salmanov, AG; Terekhov, VA; Voloshynovych, NS | 1 |
Aghdaei, HA; Azimirad, M; Ebrahimi Daryani, N; Firuzabadi, S; Hagh Azalli, M; Hemmasi, G; Houri, H; Khorsand, B; Malekpour, H; Mohebi, SR; Rafieepoor, M; Sadeghi, A; Sherkat, G; Soleymani, G; Soltanpoor, F; Talaei, R; Tanhaei, M; Yadegar, A; Zali, MR; Zamani, F | 1 |
Arantes, T; Costa, SF; de Assis, DB; de Oliveira, MS; Falcão, MAP; Freire, MP; Girão, ES; Guimaraes, T; Levin, AS; Mendes, ET; Perdigão Neto, LV; Porto, APM; Tavares, BM | 1 |
Martinez, AI; Santos, CAQ; Trick, WE; Tseng, M; Varughese, CA; Won, SY; Zhang, H | 1 |
Guo, S; Li, X; Li, Y; Shao, J; Tian, M; Tong, H; Wei, M; Xu, B; Yan, B | 1 |
Aguirre-Burciaga, E; Alcaraz-Espejel, M; Avilés-Benítez, LK; Barlandas-Rendón, NRE; Barroso-Herrera-Y-Cairo, IE; Bocanegra-Ibarias, P; Bolado-Martinez, E; Camacho-Ortiz, A; Carnalla-Barajas, MN; Cetina-Umaña, CM; Cobos-Canul, DI; Colin, C; Couoh-May, CA; Duarte, L; Echaniz-Aviles, G; Escalante-Armenta, SP; Feliciano-Guzmán, JM; Garza-González, E; Gil, M; Gómez-Choel, AC; Hernández-Cordova, IY; Hernández-Dueñas, AMDR; Huirache-Villalobos, GS; López, D; Lopez, L; López-García, M; López-Gutiérrez, E; López-Jácome, LE; Martínez-Gamboa, RA; Mena-Ramirez, JP; Molina, A; Mora-Jiménez, I; Morales-de-la-Peña, CT; Morfin-Otero, R; Munoz, S; Newton-Sánchez, OA; Ortiz-Brizuela, E; Padilla-Ibarra, C; Peralta-Catalán, R; Perez-Ricardez, ML; Ponce-de-Leon, A; Quevedo-Ramos, MA; Quintanilla-Cazares, LJ; Rincón-Zuno, J; Rivera-Ferreira, MC; Rodriguez-Noriega, E; Rodriguez-Zulueta, P; Rojas-Larios, F; Romero, D; Ruiz-Gamboa, LA; Soto, A; Tinoco, JC; Velázquez-Acosta, MDC; Zubiate, H | 1 |
Eşki, F; Gökmen, TG; Karahan, Ş; Kıvrak, İ; Özdemir, Y; Sevin, S; Sezer, O; Turut, N; Ütük, AE; Yazgan, H | 1 |
15 review(s) available for vancomycin and carbapenems
Article | Year |
---|---|
An overview of antimicrobial therapy.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Humans; Macrolides; Microbial Sensitivity Tests; Monobactams; Penicillins; Sulfonamides; Vancomycin | 1992 |
Antibiotic choices in surgical intensive care unit patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Carbapenems; Cephalosporins; Critical Care; Drug Resistance, Microbial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monobactams; Mycoses; Penicillins; Pneumonia; Surgical Wound Infection; Vancomycin | 1991 |
Pharmacodynamics of antimicrobial therapy in surgery.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Surgical Procedures, Operative; Vancomycin | 1996 |
[Penicillin-resistant Streptococcus pneumoniae infections: current trends in epidemiology and antibiotic chemotherapy].
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Humans; Japan; Mice; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 2000 |
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
[Fever in patients with cancer].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbapenems; Diagnosis, Differential; Drug Therapy, Combination; Fever; Humans; Naproxen; Neoplasms; Neutropenia; Opportunistic Infections; Vancomycin | 2009 |
Pharmacotherapy in the critically ill obese patient.
Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin | 2010 |
Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Critical Care; Daptomycin; Echinocandins; Fluoroquinolones; Humans; Linezolid; Oxazolidinones; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Renal Insufficiency; Vancomycin | 2011 |
Management of antibiotic-resistant infection in the newborn.
Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Colistin; Daptomycin; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Linezolid; Oxazolidinones; Vancomycin | 2011 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Antibiotic resistance in Bangladesh: A systematic review.
Topics: Anti-Bacterial Agents; Bangladesh; Carbapenems; Databases, Factual; Drug Resistance, Multiple, Bacterial; Enterococcus; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae; Vancomycin | 2019 |
Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
Topics: Acute Kidney Injury; Adolescent; Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cephalosporins; Child; Child, Preschool; Critical Illness; Drug Monitoring; Female; Half-Life; Humans; Infant; Infusions, Intravenous; Male; Penicillins; Vancomycin; Young Adult | 2020 |
Brazilian perspective: antimicrobial stewardship in solid organ transplant.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Brazil; Carbapenems; Humans; Organ Transplantation; Transplant Recipients; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
2 trial(s) available for vancomycin and carbapenems
Article | Year |
---|---|
Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Counseling; Drug Prescriptions; Drug Utilization; Female; Guideline Adherence; Hospitals; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organizational Policy; Vancomycin | 2008 |
Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Therapy, Combination; Humans; Korea; Linezolid; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2009 |
65 other study(ies) available for vancomycin and carbapenems
Article | Year |
---|---|
The antibacterial activity of meropenem in combination with gentamicin or vancomycin.
Topics: Carbapenems; Colony Count, Microbial; Culture Media; Drug Therapy, Combination; Gentamicins; Kinetics; Meropenem; Methicillin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins; Vancomycin | 1989 |
In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
Topics: Animals; Bacterial Proteins; Carbapenems; Carrier Proteins; Cell Wall; Endocarditis, Bacterial; Hexosyltransferases; Imidazoles; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1996 |
[Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Burns; Carbapenems; Carrier Proteins; Drug Resistance, Microbial; Drug Synergism; Hexosyltransferases; Methicillin Resistance; Mice; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Dipeptidases; Imipenem; Kidney; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscle, Skeletal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci.
Topics: Anti-Bacterial Agents; Carbapenems; Gram-Positive Bacteria; Imipenem; Kinetics; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1997 |
[In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Topics: Anti-Bacterial Agents; Carbapenems; Imipenem; Meropenem; Methicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1998 |
[In vitro antibacterial activity of vancomycin in combination with panipenem against carbapenem-resistant MRSA].
Topics: Carbapenems; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Hydrogen-Ion Concentration; Methicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1998 |
In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Coagulase; Colony Count, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins; Vancomycin | 2000 |
In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
Topics: Abscess; Acetamides; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Dipeptidases; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hexosyltransferases; Kidney; Linezolid; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Oxazolidinones; Penicillin-Binding Proteins; Peptidyl Transferases; Vancomycin; Vancomycin Resistance | 2003 |
[Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Pseudomonas aeruginosa isolated in major hospitals in Nagano prefecture].
Topics: Ampicillin Resistance; Carbapenems; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Streptococcus pneumoniae; Vancomycin | 2004 |
Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2005 |
Insufficient therapy for nosocomial meningitis negatively affects survival, sequellae and has social consequences.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Retrospective Studies; Treatment Failure; Vancomycin | 2007 |
Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.
Topics: Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 2008 |
Nosocomial bloodstream infection in a pediatric intensive care unit.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Medical Records; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome; Vancomycin | 2008 |
Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Bronchopneumonia; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Humans; Lung; Male; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Specific Pathogen-Free Organisms; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Carbapenems; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Pneumonia, Staphylococcal; Staphylococcus aureus; Tissue Distribution; Vancomycin; Vancomycin Resistance | 2008 |
Trends in antibacterial use in US academic health centers: 2002 to 2006.
Topics: Academic Medical Centers; Adult; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; United States; Vancomycin | 2008 |
Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Carbapenems; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatitis; Retrospective Studies; Vancomycin | 2012 |
[Microbial spectrum of nosocomial pneumonia in traumatological patients].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Hospitals; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Wounds and Injuries | 2011 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009.
Topics: Acetamides; Acinetobacter baumannii; Carbapenems; Drug Evaluation; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Humans; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Skin; Skin Diseases, Bacterial; Tigecycline; Vancomycin | 2012 |
Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline; Vancomycin | 2012 |
Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterococcus faecium; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Longitudinal Studies; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline; Vancomycin | 2012 |
Impact of penicillin nonsusceptibility on clinical outcomes of patients with nonmeningeal Streptococcus pneumoniae bacteremia in the era of the 2008 clinical and laboratory standards institute penicillin breakpoints.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Child; Child, Preschool; Female; Humans; Infant; Length of Stay; Male; Middle Aged; Penicillin Resistance; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Survival Rate; Treatment Outcome; Vancomycin | 2012 |
Antibiotic exposure and IBD development among children: a population-based cohort study.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Cefoxitin; Child; Child, Preschool; Clindamycin; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Inflammatory Bowel Diseases; Logistic Models; Male; Metronidazole; Penicillins; Proportional Hazards Models; Retrospective Studies; Risk; Tetracycline; United Kingdom; Vancomycin | 2012 |
Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Larva; Lipid A; Microbial Sensitivity Tests; Moths; Signal Transduction; Vancomycin | 2013 |
Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis.
Topics: Aged; Carbapenems; Communicable Diseases; Drug Utilization; Drug Utilization Review; Female; Humans; Male; Middle Aged; Prescriptions; Prospective Studies; Tertiary Care Centers; Vancomycin | 2013 |
Outcomes associated with a thrice-weekly antimicrobial stewardship programme in a 253-bed community hospital.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Hospitals, Community; Humans; Retrospective Studies; Vancomycin | 2013 |
History of antibiotics: from fluoroquinolones to daptomycin (Part 2).
Topics: Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; History, 20th Century; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Vancomycin | 2013 |
Antibiotic resistance: the last resort.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Centers for Disease Control and Prevention, U.S.; Drug Resistance, Bacterial; Enterobacteriaceae; Epidemiological Monitoring; Humans; Infection Control; Internationality; Israel; Klebsiella Infections; Klebsiella pneumoniae; Public Health Surveillance; Shock, Septic; United States; Vancomycin | 2013 |
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2013 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
Impact of Clostridium difficile recurrence on hospital readmissions.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Fluoroquinolones; Humans; Intensive Care Units; Linezolid; Multivariate Analysis; Patient Readmission; Recurrence; Regression Analysis; Retrospective Studies; Vancomycin | 2015 |
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins; Vancomycin; Young Adult | 2015 |
The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Carrier State; Case-Control Studies; Drug Resistance, Bacterial; Fecal Incontinence; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Metronidazole; Middle Aged; Organ Transplantation; Respiration, Artificial; Risk Factors; Stem Cell Transplantation; Thienamycins; Time Factors; Vancomycin | 2016 |
Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Japan; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Sex Factors; Vancomycin | 2015 |
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin | 2015 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
Variation in Postinjury Antibiotic Prophylaxis Patterns Over Five Years in a Combat Zone.
Topics: Afghan Campaign 2001-; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Cefazolin; Fluoroquinolones; Guideline Adherence; Humans; Injury Severity Score; Iraq War, 2003-2011; Logistic Models; Military Personnel; Practice Patterns, Physicians'; Retrospective Studies; Vancomycin; Warfare; Wounds and Injuries | 2017 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Child; Child, Preschool; Drug Utilization; Female; Gram-Positive Bacteria; Hematopoietic Stem Cell Transplantation; Hospital Mortality; Hospitals, Pediatric; Humans; Leukemia; Male; Penicillins; Registries; Regression Analysis; Retrospective Studies; Vancomycin | 2018 |
The impact of earlier intervention by an antimicrobial stewardship team for specific antimicrobials in a single weekly intervention.
Topics: Anti-Infective Agents; Antimicrobial Stewardship; Carbapenems; Daptomycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Retrospective Studies; Teicoplanin; Time Factors; Treatment Outcome; Vancomycin | 2018 |
Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study.
Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Colistin; Communicable Diseases; Cost-Benefit Analysis; Drug Utilization; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Population Surveillance; Saudi Arabia; Tertiary Care Centers; Vancomycin; Young Adult | 2018 |
In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Rifampin; Vancomycin | 2019 |
Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin; Young Adult | 2019 |
Antimicrobial consumption in three pediatric and neonatal intensive care units in Saudi Arabia: 33-month surveillance study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Epidemiological Monitoring; Female; Humans; Infant; Intensive Care Units, Neonatal; Male; Pediatrics; Prospective Studies; Saudi Arabia; Vancomycin | 2019 |
Effect of Antimicrobial Stewardship on Outcomes in Patients With Cancer or Undergoing Hematopoietic Stem Cell Transplantation.
Topics: Antimicrobial Stewardship; Carbapenems; Enterococcus; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Vancomycin | 2020 |
Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Minocycline; Sulbactam; Vancomycin | 2020 |
Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2020 |
Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
Topics: Acinetobacter; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Health Facilities; Hospitals; Humans; Klebsiella; Methicillin-Resistant Staphylococcus aureus; Prevalence; Prospective Studies; Pseudomonas; Saudi Arabia; Vancomycin | 2020 |
Evaluation of Allplex™ Entero-DR assay for detection of antimicrobial resistance determinants from bacterial cultures.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carbon-Oxygen Ligases; Drug Resistance, Bacterial; Enterococcus; Gram-Negative Bacteria; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Vancomycin | 2020 |
Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Carbapenems; Controlled Before-After Studies; Female; Humans; Interrupted Time Series Analysis; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Practice Guidelines as Topic; Retrospective Studies; Stem Cell Transplantation; Vancomycin | 2020 |
Decreasing incidence of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin | 2022 |
Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.
Topics: Animals; Anti-Bacterial Agents; Arginine; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromatography, Liquid; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Tandem Mass Spectrometry; Urinary Tract Infections; Vancomycin | 2022 |
HEALTHCARE-ASSOCIATED TUBO-OVARIAN INFECTIONS IN UKRAINE: RESULTS OF A MULTICENTER STUDY (2020-2022).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Methicillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ukraine; Vancomycin | 2022 |
High Prevalence Rate of Microbial Contamination in Patient-Ready Gastrointestinal Endoscopes in Tehran, Iran: an Alarming Sign for the Occurrence of Severe Outbreaks.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactamases; Carbapenems; Disease Outbreaks; Endoscopes, Gastrointestinal; Humans; Iran; Microbial Sensitivity Tests; Prevalence; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Computing antimicrobial use/antimicrobial resistance ratios: A novel way to assess inpatient antimicrobial utilization using current National Healthcare Safety Network metrics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Benchmarking; Carbapenems; COVID-19 Drug Treatment; Daptomycin; Delivery of Health Care; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Inpatients; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Vancomycin | 2022 |
Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Escherichia coli; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Vancomycin | 2022 |
Bacterial incidence and drug resistance from pathogens recovered from blood, cerebrospinal and pleural fluids in 2019-2020. Results of the Invifar network.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Resistance; Escherichia coli; Humans; Incidence; Levofloxacin; Retrospective Studies; Vancomycin | 2023 |
Chemical composition and antibacterial activity of bee venom against multi-drug resistant pathogens.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bee Venoms; Carbapenems; Escherichia coli; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2023 |